Differences

This shows you the differences between two versions of the page.

--- home:mp:progress [04.29.2019] – [Concerns about progress on the Marshall Protocol] sallieq
+++ home:mp:progress [04.29.2019] – [“My disease is getting worse”] sallieq
@@ Line 21: / Line 21: @@
 Early on the protocol MP patients' symptoms tend to wax and wane in a semi-predictable fashion and occur in expected locations. This is particularly true if a regular schedule of dosing is followed. However, as a patient's own immune response begins to take hold, predictability become more elusive. Patients may even notice new symptoms occurring in organs previously not known to be infected. The MP does not and cannot create new inflammation.
-<blockquote>
+Later on in the protocol, Biofilm is likely to break up, leading to unpredictable surges in immuno-pathology.
-In cases where people have trouble grasping this concept, the biggest hurdle is to get them through the first phase of the treatment when the immunopathology is often strongest. If I have any dropouts, they come from this group – the people who can’t intellectually grasp the idea that they need to feel worse before they get better.
-//**Greg Blaney, MD**// </blockquote>
+<blockquote>  In cases where people have trouble grasping this concept, the biggest hurdle is to get them through the first phase of the treatment when the immunopathology is often strongest. If I have any dropouts, they come from this group – the people who can’t intellectually grasp the idea that they need to feel worse before they get better.
+//**Greg Blaney, MD**//
+</blockquote>
 The immunopathological reaction (sometimes referred to as the Jarisch-Herxheimer reaction) is widely accepted as an indication of progress and, according to the literature, [[home:protocol:immunopathology|has been observed]] in at least ten different diseases and conditions.

home/mp/progress.txt · Last modified: 09.14.2022 by 127.0.0.1